The Protective Effects of Ivabradine in Preventing Progression from Viral Myocarditis to Dilated Cardiomyopathy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Protective Effects of Ivabradine in Preventing Progression from Viral Myocarditis to Dilated Cardiomyopathy
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-11-01
DOI
10.3389/fphar.2016.00408
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nicotine inhibits the production of proinflammatory cytokines of mice infected with coxsackievirus B3
- (2016) Ge Li-Sha et al. LIFE SCIENCES
- Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3
- (2015) Ge Li-Sha et al. Scientific Reports
- Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis
- (2013) Yue-Chun Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Evidence of a synergistic association between heart rate, inflammation, and cardiovascular mortality in patients undergoing coronary angiography
- (2012) B. O Hartaigh et al. EUROPEAN HEART JOURNAL
- Role of Heart Rate Reduction in the Prevention of Experimental Heart Failure
- (2012) Peter Moritz Becher et al. HYPERTENSION
- Anti-inflammatory effects of ivabradine in patients with acute coronary syndrome: a pilot study
- (2012) Alberto Dominguez-Rodriguez et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Comparison of Effects of Ivabradine versus Carvedilol in Murine Model with the Coxsackievirus B3-Induced Viral Myocarditis
- (2012) Li Yue-Chun et al. PLoS One
- MAPK-Activated Protein Kinase-2 in Cardiac Hypertrophy and Cyclooxygenase-2 Regulation in Heart
- (2010) John M. Streicher et al. CIRCULATION RESEARCH
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
- (2010) Karl Swedberg et al. LANCET
- Ivabradine Reduces Chemokine-Induced CD4-Positive Lymphocyte Migration
- (2010) Thomas Walcher et al. MEDIATORS OF INFLAMMATION
- Dominant-negative p38α mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus
- (2009) Rajarajan A. Thandavarayan et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis — ongoing inflammation and an imbalance of the matrix degrading system
- (2009) Susanne Rutschow et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Immunomodulation and matrix metalloproteinases in viral myocarditis
- (2009) Dirk Westermann et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Heart Rate as a Risk Factor for Cardiovascular Disease
- (2009) Christine Perret-Guillaume et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents
- (2008) G Heusch BRITISH JOURNAL OF PHARMACOLOGY
- Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice
- (2008) Florian Custodis et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started